Finally, we provide a network of trans-targets of FAM30A and MIR600HG, emphasizing the most prominent one, IFNLR1, and further corroborating the regulatory involvement of FAM30A in B-cell signaling, immunoglobulin gene expression, antibody production, and, consequently, in LN disease activity. The gene discussed is FAM30A; the disease is lobular neoplasia.